Recombinant Human Endostatin Injection

DRUG2 trials

Sponsors

Peking University Third Hospital, The First Affiliated Hospital of Xinxiang Medical College

Conditions

Cervical CancerLocally Advanced Squamous Non-small Cell Lung Cancer

Phase 2

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Not yet recruitingNCT06279754

The First Affiliated Hospital of Xinxiang Medical CollegeLocally Advanced Squamous Non-small Cell Lung Cancer

Start: 2024-02-18End: 2025-12-18Target: 30Updated: 2024-02-28

Unknown Phase

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Not yet recruitingNCT05879796

Peking University Third HospitalCervical Cancer

Start: 2023-05-16End: 2026-05-16Target: 30Updated: 2023-05-30